Novartis Oncology
- Our Company
- Novartis Oncology
Bold in our pursuit to reimagine medicine
Novartis Oncology is inspired by patients to revolutionize the research, development and manufacturing of innovative, high quality medicines that help to improve and extend people’s lives.
From Cancer to Cures
Our new monthly series "Let's Talk About the C Word: From Cancer to Cures" featuring President of Novartis Oncology Dr. Susanne Schaffert, addresses challenging cancer related topics.
Sound up for lung cancer research
Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.
Novartis at ASH
Find the latest resources about Novartis data featured at the American Society of Hematology (ASH) Annual Meeting & Exposition.
"Cancer is a chapter in history we will rewrite. Novartis is positioned to reimagine cancer and transform the lives of patients around the world."
Stay up-to-date on Novartis Oncology news and stories.
Our scientists are breaking through the barriers to transform cancer care and reimagine medicine.
-
25+
Conditions treated worldwide
-
30
New molecular entities in our global clinical pipeline
Learn about Novartis immuno-oncology research
Immuno-oncology researchers seek to build smart drug combos
When science and passion connect, innovation happens. Join us.
- US Scientific Communications Associate Director/Director
East Hanover, NJ, USA
- Public Affairs Manager
Buenos Aires, Argentina
- P&O Head Oncology Mexico
Distrito Federal, Mexico
- Medical Advisor Oncology
Bucharest, Romania
